Showing results (1-10 of 474) with videos related to
Sort By:
Pageof 48
Drugs in R&D|November 24, 1999
Promising new agents in osteoporosisJ Y Reginster, Y Henrotin, C GossetRevue Medicale De Liege|April 11, 2001
[Pharmacy clinics. How I treat...arthritis. First part: pathophysiologic recurrence and symptomatic treatment]J Y Reginster, Y HenrotinRevue Medicale De Liege|May 8, 2001
[Pharmacy clinics. How I treat...Osteoarthritis. 2nd part: new therapeutic perspectives]J Y Reginster, Y HenrotinRevue Medicale De Liege|August 29, 2001
[What is the role of aceclofenac in the therapeutic arsenal against chronic osteoarthritis pathologies?]J Y Reginster, I Paul, Y HenrotinRevue Medicale De Liege|August 11, 2001
[Biochemical mediators of inflammation]Y Henrotin, G Deby-Dupont, J Y ReginsterCurrent Rheumatology Reports|December 21, 2000
Evidence of nutriceutical effectiveness in the treatment of osteoarthritisJ Y Reginster, V Gillot, O Bruyere, et al.Clinical Rheumatology|March 1, 1989
Effects of etodolac on human chondrocytes cultivated in three dimensional cultureY Henrotin, C Bassleer, J Y Reginster, et al.Osteoarthritis and Cartilage|January 30, 2003
Is there any rationale for prescribing hormone replacement therapy (HRT) to prevent or to treat osteoarthritis?J-Y Reginster, A Kvasz, O Bruyere, et al.Bulletin of the World Health Organization|November 6, 2001
Secular increase in the incidence of hip fractures in Belgium between 1984 and 1996: need for a concerted public health strategyJ Y Reginster, P Gillet, C GossetEndocrinology and Metabolism Clinics of North America|July 21, 1998
Therapy for osteoporosis. Miscellaneous and experimental agentsJ Y Reginster, A N Taquet, C GossetPageof 48